Together with Crossject's upcoming U.S. bioequivalence study, the manufactured batches and the new registration batches ...

The Houston-based firm is set to scale up its Flu/Covid test manufacturing for the current respiratory virus season.

The campaign “caused Americans to lose trust in the public health system,” House Energy and Commerce Committee Chair Cathy ...

As expected, the FDA has moved quickly to grant emergency use authorisation (EUA) to two new-generation COVID-19 mRNA vaccines from Pfizer/BioNTech and Moderna, both targeting the new Omicron ...

The Pfizer/BioNTech bivalent COVID-19 vaccine (Original and Omicron BA.4/BA.5) has the FDA’s EUA for use in individuals 5 years and over as a single booster dose administered at least two months ...

On September 10, experts across disciplines, from infectious disease clinicians to regulators to representatives from the pharmaceutical industry, convened at the inaugural ImmunOptimize workshop in ...

An 800% increase in licensing deal values indicates growing confidence in mRNA technology, but some vaccine producers are ...

The modified vaccinia Ankara-Bavarian Nordic mpox vaccine (MVA-BN; Jynneos) generated robust immune responses in adolescents ...

has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for active immunization to prevent COVID-19 in individuals aged 12 and older. Novavax's vaccine is ...

Kamala Harris is not offering sweeping change, even as voters express dissatisfaction about the direction of the country. She’s an institutionalist who wants to preserve democratic ideals, and ...